Tekla Capital Management

Tekla Capital Management

$113,800,000 IPO
PE HUB

Biopharma firm Atreca goes public

FinSMEs

Pfizer Acquires Clinical-Stage Biotech Company Therachon, for Up To $810M

Silicon Canals

Swiss startup Oculis secures €13.8M funding to treat ophthalmic diseases

$15,711,870 Venture capital (Series B)
FinSMEs , PE HUB

Oculis Raises CHF15.5M in Extension of Series B Financing

$80,000,000 Venture capital
FinSMEs

Milestone Pharmaceuticals Raises $80M in Equity Funding

Funding Health
$125,000,000 Venture capital (Series C)
FinSMEs , PE HUB , MedCity News

Atreca Raises $125M in Series C Funding

Funding
$60,000,000 Venture capital (Series B)
FinSMEs

Biotech Company Therachon Raises $60M Mezzanine Financing

Funding Health
$20,000,000 Venture capital (Series B)
FinSMEs

BioClin Therapeutics Raises $20M; Completes $50M Series B Financing

Funding Health
PE HUB

| Oculis nabs $20.3 mln Series B

Funding Health
$20,300,000 Venture capital (Series B)
Norðurskautið , FinSMEs

Oculis raises $20.3m Series B round to advance treatment for Ophthalmic Diseases

Funding Health
$35,000,000 Venture capital (Series B)
PE HUB , PE HUB

Atreca raises $35 mln Series B co-led by Wellington

Funding
$75,000,000 IPO
Xconomy

With $75M Haul, Ovid Continues Flurry of Biotech IPOs

Health Science
$30,000,000 Venture capital (Series B)
PE HUB , Xconomy

BioClin Therapeutics inks $30 mln Series B

Messaging Funding Data leaks
$5,000,000 Venture capital (Series A)
Therachon

Therachon Appoints Luca Santarelli, M.D., as Chief Executive Officer and Extends Series A Financing

Venture capital (Series A)
Norðurskautið

Oculis Pharma raises Series A led by Brunnur Ventures and Silfurberg

Health Funding
$35,000,000 Venture capital (Series A)
businesswire

Therachon Secures $35 Million Financing | Business Wire

$75,000,000 Venture capital (Series B)
Xconomy

Ex-Teva CEO's Brain Disease Startup, Ovid, Bags $75M From Crossovers

Health Funding